From 1st December, all travellers from the Common Travel Area (the United Kingdom, Republic of Ireland, Jersey and the Isle of Man) regardless of vaccination status will need to purchase and complete a course of lateral flow tests. There are no other restrictions for these travellers.
The Guernsey Contingencies Authority has confirmed that it will introduce lateral flow tests on arrival for those travelling from within the Common Travel Area who are vaccinated or unvaccinated with a travel history of only the Common Travel Area in the last 10 days.
All travellers will have to pay £25 per travelling adult for a pack of five lateral flow tests that they will receive on arrival. This charge will be collected at the point of the traveller completing the Travel Tracker. Travellers are asked to take the lateral flow test every other day, to help protect themselves and the wider community.
For all other countries, travel requirements will depend on whether or not the traveller is fully vaccinated. Fully vaccinated non-CTA arrivals will be required to take a self-swab PCR test on arrival at the port and self-isolate until negative. Unvaccinated non-CTA arrivals will need to take a self-swab PCR test on arrival at the port, and self-isolate until they take a second PCR test on Day 8 and receive a negative result.
It is also strongly recommended that those who are not local residents arrange to take a pre-travel test (either PCR or lateral flow). Visitors who arrange to be tested pre-travel will protect themselves and their families from the costs and difficulties they will experience if they subsequently test positive after arriving in the Bailiwick. In addition, this will afford additional protection to those who travel with them on the same flight or ferry and to others within our Islands.
This will be kept under regular review.
Red List Countries
As a reminder any countries placed on the UK’s red list will also be treated as red list countries for the purpose of travel to the Bailiwick. This action is being taken as a precautionary response to the new COVID-19 variant B.1.1.529 which is currently considered a Variant Under Investigation by the UK Health Security Agency.